Caseware UK (AP4) 2024.0.164 2024.0.164 2024-04-01No description of principal activitytrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false22false 07832201 2024-04-01 2025-03-31 07832201 2023-04-01 2024-03-31 07832201 2025-03-31 07832201 2024-03-31 07832201 c:Director1 2024-04-01 2025-03-31 07832201 d:OfficeEquipment 2024-04-01 2025-03-31 07832201 d:OfficeEquipment 2025-03-31 07832201 d:OfficeEquipment 2024-03-31 07832201 d:OfficeEquipment d:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 07832201 d:CurrentFinancialInstruments 2025-03-31 07832201 d:CurrentFinancialInstruments 2024-03-31 07832201 d:CurrentFinancialInstruments d:WithinOneYear 2025-03-31 07832201 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 07832201 d:ShareCapital 2025-03-31 07832201 d:ShareCapital 2024-03-31 07832201 d:RetainedEarningsAccumulatedLosses 2025-03-31 07832201 d:RetainedEarningsAccumulatedLosses 2024-03-31 07832201 c:FRS102 2024-04-01 2025-03-31 07832201 c:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 07832201 c:FullAccounts 2024-04-01 2025-03-31 07832201 c:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure
Company registration number: 07832201











ELKIMIA LIMITED
Unaudited
Financial statements
Information for filing with the registrar
For the Year Ended 31 March 2025

















Coveney Nicholls Limited
Chartered Accountants
The Old Wheel House
31/37 Church Street
Reigate
Surrey
UK
RH2 0AD

 
ELKIMIA LIMITED
Registered number:07832201

Statement of Financial Position
As at 31 March 2025

2025
2024
Note
£
£

Fixed assets
  

Tangible assets
 4 
-
11

  
-
11

Current assets
  

Cash at bank and in hand
 5 
156
156

  
156
156

Creditors: amounts falling due within one year
 6 
(6,556)
(6,087)

Net current liabilities
  
 
 
(6,400)
 
 
(5,931)

Total assets less current liabilities
  
(6,400)
(5,920)

  

Net liabilities
  
(6,400)
(5,920)


Capital and reserves
  

Called up share capital 
  
100
100

Profit and loss account
  
(6,500)
(6,020)

  
(6,400)
(5,920)


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 21 December 2025.




Dr Yusuf Rajbee
Director
Page 1

 
ELKIMIA LIMITED
Registered number:07832201
    
Statement of Financial Position (continued)
As at 31 March 2025


The notes on pages 3 to 6 form part of these financial statements.

Page 2

 
ELKIMIA LIMITED
 
 
Notes to the Financial Statements

For the Year Ended 31 March 2025

1.


General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 49 Hazelwood Avenue, Morden, Surrey, SM4 5RS, England.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

Going concern

The directors have made due enquiries and have continued to adopt the going concern basis in preparing the financial statements which assumes that the company will continue in operation for the foreseeable future

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

The company earns revenue from the provision of medical services.

 
2.4

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Page 3

 
ELKIMIA LIMITED
 
 
Notes to the Financial Statements

For the Year Ended 31 March 2025

2.Accounting policies (continued)


2.4
Tangible fixed assets (continued)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on a reducing balance basis.

Depreciation is provided on the following basis:

Office equipment
-
33%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.5

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.6

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


3.


Employees

The average monthly number of employees, including directors, during the year was 2 (2024 - 2).

Page 4

 
ELKIMIA LIMITED
 
 
Notes to the Financial Statements

For the Year Ended 31 March 2025

4.


Tangible fixed assets





Office equipment

£



Cost or valuation


At 1 April 2024
162



At 31 March 2025

162



Depreciation


At 1 April 2024
151


Charge for the year on owned assets
11



At 31 March 2025

162



Net book value



At 31 March 2025
-



At 31 March 2024
11


5.


Cash and cash equivalents

2025
2024
£
£

Cash at bank and in hand
156
156

156
156



6.


Creditors: Amounts falling due within one year

2025
2024
£
£

Other creditors
6,052
5,307

Accruals and deferred income
504
780

6,556
6,087





Page 5

 
ELKIMIA LIMITED
 
 
Notes to the Financial Statements

For the Year Ended 31 March 2025
7.
Director's advances, credits and guarantees

During the year the directors entered into the following advances and credits with the company:


2025

Balance brought forward 
Advances/(credits) to the directors
Amounts repaid
Balance outstanding

£
£
£
£

Dr Yusuf Rajbee
(5,308)
-
(744)
(6,052)

2024

Balance brought forward 
Advances/(credits) to the directors
Amounts repaid
Balance outstanding

£
£
£
£

Dr Yusuf Rajbee
(4,845)
16,926
(17,389)
(5,308)

 
Page 6